Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019;9(3):123-127.
doi: 10.15171/bi.2019.16. Epub 2019 Mar 8.

Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates

Mostafa Akbarzadeh Khiavi  1   2 , Azam Safary  2   3 , Mohammad Hossein Somi  1
Affiliations
Editorial

Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates

Mostafa Akbarzadeh Khiavi et al. Bioimpacts. 2019.

Abstract

Despite rapid advances in diagnostic and treatment approaches, the overall survival rate of cancer has not been improved. Colorectal cancer (CRC) is recognized as the third leading cause of neoplasm-related deaths worldwide, in large part due to its considerable metastasis and drug resistance. For developing new anticancer strategies, rapid progression of multimodal nanomedicines and nanoconjugates has provided promising treatment modalities for effective therapy of cancer. The limitations of cancer chemotherapy might be overcome through the use of such nanosized therapeutics, including nanoconjugates of monoclonal antibodies (mAbs) along with drugs and organic/inorganic nanoparticles. CRC cells express various molecular markers against which mAbs can be designed and used as targeting/therapeutic agents. This editorial highlights the importance of such targeted nanosystems against CRC.

Keywords: Colorectal cancer; Monoclonal antibodies; Nanocarrier; Nanoconjugates; Nanomedicines; Targeted therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zarour LR, Anand S, Billingsley KG, Bisson WH, Cercek A, Clarke MF. et al. Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cell Mol Gastroenterol Hepatol. 2017;3:163–73. doi: 10.1016/j.jcmgh.2017.01.006. - DOI - PMC - PubMed
    1. Mirinezhad SK, Moaddab SY, Shirazi KM, Bonyadi MJ, Eftekharsadat AT, Grami SMN. et al. Clinical and Genetic Characterization of Familial Adenomatous Polyposis: An Iranian Population Study. Iranian Red Crescent Medical Journal. 2018;20(4):e64254. doi: 10.5812/ircmj.64254. - DOI
    1. Mirinezhad SK, Mousavi F, Baghri M, Sepehri B, Ghavidel A, Ghojazadeh M. et al. Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran. Asian Pac J Cancer Prev. 2018;19:167–9. doi: 10.22034/apjcp.2018.19.1.167. - DOI - PMC - PubMed
    1. Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B. et al. Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol. 2013;86:232–50. doi: 10.1016/j.critrevonc.2012.09.014. - DOI - PMC - PubMed
    1. Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2010;596:47–76. doi: 10.1007/978-1-60761-416-6_4. - DOI - PubMed

Publication types

LinkOut - more resources